IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,893 | -41.2% | 11,405 | -9.1% | 0.03% | -38.5% |
| Q2 2023 | $88,296 | -3.7% | 12,542 | -16.4% | 0.05% | +4.0% |
| Q1 2023 | $91,705 | -30.9% | 15,009 | -27.8% | 0.05% | -27.5% |
| Q4 2022 | $132,797 | +2.2% | 20,782 | +53.7% | 0.07% | +32.7% |
| Q3 2022 | $130,000 | -12.2% | 13,519 | +0.8% | 0.05% | -5.5% |
| Q2 2022 | $148,000 | +2.8% | 13,415 | +54.9% | 0.06% | -14.1% |
| Q1 2022 | $144,000 | -17.7% | 8,663 | -5.7% | 0.06% | -3.0% |
| Q4 2021 | $175,000 | -20.1% | 9,182 | +3.2% | 0.07% | -31.2% |
| Q3 2021 | $219,000 | -10.2% | 8,901 | -5.0% | 0.10% | -4.0% |
| Q2 2021 | $244,000 | +29.1% | 9,371 | +56.9% | 0.10% | +25.0% |
| Q1 2021 | $189,000 | -30.5% | 5,971 | +1.7% | 0.08% | -29.2% |
| Q4 2020 | $272,000 | -20.9% | 5,870 | -43.8% | 0.11% | -37.2% |
| Q3 2020 | $344,000 | +5.5% | 10,450 | -12.0% | 0.18% | +16.9% |
| Q2 2020 | $326,000 | -20.9% | 11,869 | -13.7% | 0.15% | -9.4% |
| Q1 2020 | $412,000 | -5.5% | 13,751 | -12.8% | 0.17% | +139.4% |
| Q4 2019 | $436,000 | +80.9% | 15,764 | +19.2% | 0.07% | +44.9% |
| Q3 2019 | $241,000 | -29.5% | 13,225 | -5.3% | 0.05% | -31.9% |
| Q2 2019 | $342,000 | +28.6% | 13,962 | -53.6% | 0.07% | +60.0% |
| Q4 2018 | $266,000 | -34.5% | 30,077 | -16.7% | 0.04% | +7.1% |
| Q3 2018 | $406,000 | -48.8% | 36,120 | -41.7% | 0.04% | -94.0% |
| Q2 2018 | $793,000 | -48.4% | 61,951 | -31.9% | 0.70% | -47.5% |
| Q1 2018 | $1,537,000 | +377.3% | 90,926 | +125.9% | 1.33% | +230.2% |
| Q4 2017 | $322,000 | -23.9% | 40,259 | -26.2% | 0.40% | +608.8% |
| Q3 2017 | $423,000 | +16.2% | 54,523 | +10.1% | 0.06% | +5.6% |
| Q2 2017 | $364,000 | – | 49,536 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |